Edward Goodwin
Director/Board Member at Angel Investor Forum, Inc.
Profile
Edward Goodwin is currently a Director at Angel Investor Forum, Inc. He was previously a Director at Biopharmaceutical Research Co.
Edward Goodwin active positions
| Companies | Position | Start |
|---|---|---|
Angel Investor Forum, Inc.
 Angel Investor Forum, Inc. Financial ConglomeratesFinance Angel Investor Forum, Inc. operates as a venture capital company. It focuses four investment types: medical devices, financial services, software, and consumer products. The company was founded in 2004 and is headquartered in East Hartford, CT. | Director/Board Member | - |
Former positions of Edward Goodwin
| Companies | Position | End |
|---|---|---|
Biopharmaceutical Research Co.
 Biopharmaceutical Research Co. Pharmaceuticals: OtherHealth Technology Biopharmaceutical Research Co. is a specialty pharmaceutical company that focuses on providing safe and effective options for treating patients with innovative cannabinoid therapeutics. The company is based in Castroville, CA. The company holds several DEA registrations across the entire value chain of cannabis and is pioneering the federally legal cannabis space in the USA. BRC has full DEA compliance for botanically derived cannabinoids and has developed proprietary poly-cannabinoids in titratable dosages that are soon to enter the clinic. The company was founded in 2017 by George Bennett Hodgin, who has been the CEO since 2017. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Angel Investor Forum, Inc.
Angel Investor Forum, Inc. Financial ConglomeratesFinance Angel Investor Forum, Inc. operates as a venture capital company. It focuses four investment types: medical devices, financial services, software, and consumer products. The company was founded in 2004 and is headquartered in East Hartford, CT. | Finance |
Biopharmaceutical Research Co.
Biopharmaceutical Research Co. Pharmaceuticals: OtherHealth Technology Biopharmaceutical Research Co. is a specialty pharmaceutical company that focuses on providing safe and effective options for treating patients with innovative cannabinoid therapeutics. The company is based in Castroville, CA. The company holds several DEA registrations across the entire value chain of cannabis and is pioneering the federally legal cannabis space in the USA. BRC has full DEA compliance for botanically derived cannabinoids and has developed proprietary poly-cannabinoids in titratable dosages that are soon to enter the clinic. The company was founded in 2017 by George Bennett Hodgin, who has been the CEO since 2017. | Health Technology |
- Stock Market
- Insiders
- Edward Goodwin
